跳转到主要内容
Mantapex
Which peptides will the FDA propose adding to the 503A Bulks List?
Before Oct 1, 2027Politics
Kalshi 活跃 7 个市场·76¢ Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add KPV (free base) or KPV acetate to the 503A Bulks List before Oct 1, 2027?·$0 总交易量·-- 流动性·-- OI
12mo·Oct 9, 2027

追踪你的预测市场持仓

连接你的 Kalshi 账户,追踪你的合约、盈亏和结算。

较大价差
暂无图表数据

市场

7
Food and Drug Administration announce publication proposed rule would add KPV (free base) KPV acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add TB-500 (free base) TB-500 acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add MOTS-c (free base) MOTS-c acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add Semax (free base) Semax acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add Epitalon (free base) Epitalon acetate before Oct 2027
$0 vol
76% ▲0.0%
Food and Drug Administration announce publication proposed rule would add KPV (free base) KPV acetate before Oct 2027
暂无订单簿数据

If the U.S. Food and Drug Administration announces publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.

系列

KXPEPTIDEAPPROVE
查看完整系列

追踪您在 Kalshi 上的投注——以及一切其他资产

从您的 Kalshi 头寸、盈亏和实时赔率开始,创建免费投资组合。然后添加加密钱包、交易所、DeFi 等——一切尽在一处。

Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% 免费· 只读· 加密保护